Cerebrospinal fluid investigations for neurometabolic disorders

Neuropediatrics

Volumn 29, Issue 2, 1998, Pages 59-71

  Hoffmann, G F ^a   Surtees, R A H ^b   Wevers, R A ^c  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Biogenic amines; Cerebrospinal fluid; Epileptic encephalopathies; Folinic acid; GABA; Neurometabolic disorders

Indexed keywords

4 AMINOBUTYRIC ACID; BIOGENIC AMINE; FOLIC ACID; GLUCOSE; GLUTARYL COENZYME A DEHYDROGENASE; IMMUNOGLOBULIN; LACTIC ACID; PROTEIN; PYRUVIC ACID;

AUTONOMIC DYSFUNCTION; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN METABOLISM; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; DYSTONIA; EPILEPSY; HUMAN; MENTAL DEFICIENCY; METABOLIC DISORDER; PRIORITY JOURNAL; REVIEW;

EID: 0031972016     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-973538     Document Type: Review

References (59)

1. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. USA 93, 1945-1949 (1996).
2. Balk, J.-H., Picetti, R., Saiardi, A., Thiriet, G., Dierich, A., Depaulis, A., et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377, 424-428 (1995).
3. Barbot, C., Martins, E., Vilarinho, L., Dorche, C., Cardoso, M. L. A mild form of infantile isolated sulphite oxidase deficiency. Neuropediatrics 26, 322-324 (1995).
4. Barshop, B. A., Wolff, J., Nyhan, W. L., Yu, A., Prodanos, C., Jones, G., et al. Transcobalamin II deficiency presenting with methylmalonic aciduria and homocystinuria and abnormal absorption of cobalamin. Am. J. Med. Genet. 35, 222-228 (1990).
5. Bartholomé, K. A new molecular defect in phenylketonuria. Lancet II, 1580 (1974).
6. Beck, C., Moulard, B., Steinlein, O., Guipponi, M., Vallee, L., Montpied, P., et al. A nonsense mutation in the α4 subunit of the nicotinergic acetylcholine receptor (CHRNA4) cosegrates with 20q-linked benign neonatal familial convulsions (EBN1). Neurobiol. Disease 1, 95-99 (1994).
7. Biaggioni, I., Goldstein, D. S., Atkinson, T., Robinson, D. Dopamin β-hydroxylase deficiency in humans. Neurology 40, 370-373 (1990).
8. Blau, N. The Hyperphenylalaninemias. Marburg, Tectum Verlag (1996).
9. Blau, N., Duran, M., Blaskovics, M. (Eds.). Physician's Guide to the Laboratory Diagnosis of Inherited Metabolic Disease. London, Chapman & Hall (1996).
10. Blau, N., Renneberg, A., Hyland, K. Dihydropteridine reductase deficiency localized to the central nervous system. J. Inherit. Metabol. Dis. 21, in press (1998).
11. Brown, G. K., Haan, E. A., Kirby, D. M., Scholem, R. D., Wraith, J. E., Rogers, J. G., et al. "Cerebral" lactic acidosis: defects in pyruvate metabolism with profound brain damage and minimal systemic acidosis. Eur. J. Pediatr. 147, 10-14 (1988).
12. Brunner, H. G., Nelen, M., Breakefield, X. O., Ropers, H. H., van Oost, B. A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262, 578-580 (1993).
13. Brusilow, S. W., Maestri, N. E. Urea cycle disorders: diagnosis, pathophysiology, and treatment. In: Advances in Pediatrics. Mosby-Year Book, Inc. 127-170 (1996).
14. Clayton, P. T., Heales, S. J. R., Brand, M., Clelland, J., Surtees, R. J. An infant with clinical features, a metabolic profile and response to treatment suggestive of tyrosine hydroxylase deficiency. In: SSIEM, Proceedings of the 32nd Annual Symposium. Edinburgh, UK. 1994.
15. De Vivo, D., Garcia-Alvarez, M., Ronen, G., Trifiletti, R. Glucose transporter protein deficiency: an emerging syndrome with therapeutic implications. Int. Pediatr. 10, 51-56 (1995).
16. De Vivo, D., Trifiletti, R., Jacobson, R., Ronen, G., Behmand, R., Harik, S. Defective glucose transport across the blood-brain barrier as a cause of persistent hyopglycorrhachia, seizures, and developmental delay. N. Engl. J. Med. 325, 703-709 (1991).
17. Dhondt, J.-L. Tetrahydrobiopterin deficiencies: Lessons from the compilation of 200 patients. Dev. Brain Dysfunction 6, 141-157 (1993).
18. Dubowitz, L. M. S., Bouza, H., Hird, M. F., Jaeken, J. Low cerebrospinal fluid concentration of free gamma-aminobutyric acid in startle disease. Lancet 340, 80-81 (1992).
19. Erven, P. M. M. v., Renier, W. O., Gabreëls, F. J. M., Thijssen, H. O. M., Ruitenbeek, W., Horstink, M. W. I. M. Hypokinesia and rigidity as clinical manifestations of mitochondrial encephalomyopathy: report of three cases. Dev. Med. Child Neurol. 31, 81-97 (1989).
20. Fernandes, J., Saudubray, J. M., van den Berghe, G. (Eds.). Inborn Metabolic Diseases. Berlin, Heidelberg, New York, Springer (1995).
21. Fois, A., Cioni, M., Balestri, P., Bartalini, G., Baumgartner, R., Bachmann, C. Biotinidase deficiency: metabolites in CSF. J. Inherit. Metabol. Dis. 9, 284-285 (1986).
22. Frahm, J., Hanefeld, F. Localized proton magnetic resonance spectroscopy of cerebral metabolites. Neuropediatrics 27, 64-69 (1997).
23. Gerrits, G. P. J. M., Trijbels, J. M. F., Monnens, L. A. H., Gabreëls, F. J. M., de Abreu, R. A., Theeuwes, A. G., et al. Reference values for amino acids in cerebrospinal fluid of children using ion-exchange chromatography with fluorimetric detection. Clin. Chim. Acta 182, 271-280 (1989).
24. Gibson, K. M., Hoffmann, G. F., Hodson, A. K., Bottiglieri, T., Jakobs, C. 4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism. Neuropediatrics 29, 14-22 (1998).
25. Giros, B., Jaber, M., R. J. S, Wightman, R. M., Caron, M. G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612 (1996).
26. Hoffmann, G. F., Gibson, K. M., Trefz, F. K., Nyhan, W. L., Bremer, H. J., Rating, D. Neurological manifestations of organic acid disorders. Eur. J. Pediatr. 153, Suppl. 1, S94-S100 (1994).
27. Hoffmann, G. F. Organic acid analysis. In: Blau, N., Duran, M., Blaskovics, M. (Eds.). Physician's Guide to the Laboratory Diagnosis of Inherited Metabolic Disease. London, Chapman & Hall 31-50 (1996).
28. Hoffmann, G. F., Gibson, K. M. Disorders of organic acid metabolism. Amsterdam, Elsevier Science Publishers (1996).
29. Hoffmann, G. F., Assmann, B., Bräutigam, C., Höffken, H., Zschocke, J., Wevers, R. Störung der dopaminergen Signalverarbeitung als Ursache einer neonatalen epileptischen Enzephalopathie und eines frühkindlichen Parkinsonismus. Monatsschr. Kinderh. 145, 1008 (1997).
30. Hyland, K., Surtees, R. A. H., Rodeck, C., Clayton, P. T. Aromatic L-amino acid decarboxylase deficiency. Neurology 42, 1980-1988 (1992).
31. Hyland, K., Surtees, R. A. H., Heales, S. J. R., Bowron, A., Howells, D. W., Smith, I. Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population. Pediatr. Res. 34, 10-14 (1993).
32. Hyland, K., Buist, N. R. M., Powell, B. R., Hoffmann, G. F., Rating, D., McGrath, J., et al. Folinic acid responsive seizures: A new syndrome? J. Inherit. Metabol. Dis. 18, 177-181 (1995).
33. Hyland, K., Biaggioni, I., Elpeleg, O. N., Nygaard, T. C., Gibson, K. M. Disorders of neurotransmitter metabolism. In: Blau, N., Duran, M., Blaskovics, M. (Eds.). Physician's Guide to the Laboratory Diagnosis of Inherited Metabolic Disease, London, Chapman & Hall 79-98 (1996).
34. Hyland, K., Fryburg, J. S., Wilson, W. G., Bebin, E. M., Arnold, L. A., Gunasekera, R. S., et al. Oral phenylalanine load as a diagnostic test for dopa-responsive dystonia: a possible diagnostic test. Neurology 48, 1290-1297 (1997).
35. Ichinose, H., Ohye, T., Takahashi, E., Seki, N., Hori, T., Segawa, M., et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nature Genetics 8, 236-242 (1994).
36. Jaeken, J., Casaer, P., Cock, P. d., Corbeel, L., Eeckels, R., Eggermont, E., et al. Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolism. Neuropediatrics 15, 165-169 (1984).
37. Jaeken, J., Detheux, M., v. Maldergem, L., Foulon, M., Carchon, H., v. Schaftingen, E. 3-Phosphoglycerate dehydrogenase deficiency: an inborn error of serine biosynthesis. Arch. Dis. Child. 74, 542-545 (1996).
38. Jaeken, J., Casaer, P. Carbohydrate-deficient glycoconjugate syndromes: a new chapter of neuropaediatrics. Eur. J. Paediatr. Neurol. 1, 61-66 (1997).
39. Jakobs, C., Bojasch, M., Mönch, E., Rating, D., Siemes, H., Hanefeld, F. Urinary excretion of gamma-hydroxybutyric acid in a patient with neurological abnormalities: the probability of a new inborn error of metabolism. Clin. Chim. Acta 111, 169-178 (1981).
40. Jakobs, C., Jaeken, J., Gibson, K. M. Inherited disorders of GABA metabolism. J. Inherit. Metab. Dis. 16, 704-715 (1993).
41. Kruesi, M. J. P., Swedo, S. E., Hamburger, S. D., Potter, W. Z., Rapoport, J. L. Concentration gradient of CSF monamine metabolites in children and adolescents. Biol. Psychiatry 24, 507-514 (1988).
42. 6-dependent seizures. Dev. Med. Child. Neurol. 33, 749-750 (1991).
43. 1H-FT-NMR. Eur. J. Pediatr. 145, 260-266 (1986).
44. Lenney, J. P., Peppers, S. C., Kucera, C. M., Sjaastad, O. Homocarnosinosis: lack of serum carnosinase is the defect probably responsible for elevated brain and CSF homocarnosine. Clin. Chim. Acta 132, 157-165 (1983).
45. Lüdecke, B., Dworniczak, B., Bartholomé, K. A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum. Genet. 93, 123-125 (1995).
46. Merinero, B., Pérez-Cerdá, C., Font, L. M., Garcia, M. J., Aparicio, M., Lorenzo, G., et al. Variable clinical and biochemical presentation of seven Spanish cases with glutaryl-CoA-dehydrogenase deficiency. Neuropediatrics 26, 238-242 (1995).
47. Munnich, A., Rötig, A., Chretien, D., Saudubray, J. M., Cormie, R. V., Rustin, P. Clinical presentations and laboratory investigations in respiratory chain deficiency. Eur. J. Pediatr. 155, 262-274 (1996).
48. Neubauer, B., Fiedler, B., Himmelein, B., Kämpfer, F., Läβker, U., Schwabe, G., et al. Benign epilepsy of childhood with centrotemporal spikes: Linkage to chromosome 15q14. (1998).
49. Nygaard, T. G., Trugman, J. M., Fahn, Y. J. G. S. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 40, 66-69 (1990).
50. Saudubray, J. M., Charpentier, C. Clinical phenotypes: Diagnosis/Algorithms. In: Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D. (Eds.). Metabolic and Molecular Bases of Inherited Disease. New York, McGraw-Hill. 327-400 (1995).
51. Schulze, A., Hess, T., Wevers, R., Mayatepek, E., Bachert, P., Marescau, B., et al. Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism. J. Pediatrics 131, 626-631 (1997).
52. Shiang, R., Ryan, S., Zhu, Y.-Z., Hahn, A., O'Connell, P., Wasmuth, J. J. Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nature Genetics 8, 136-140 (1993).
53. Stabler, S. P., Allen, R. H., Barrett, R. E., Savage, D. G., Lindenbaum, J. Cerebrospinal fluid methylmalonic acid levels in normal subjects and patients with cobalamin deficiency. Neurology 41, 1627-1632 (1991).
54. Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., et al. Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr. Res. 36, 409-113 (1994).
55. Surtees, R., Hyland, K. Cerebrospinal fluid concentrations of S-adenosylmethionine, methionine and 5-methyltetrahydrofolate in a reference population: cerebrospinal fluid S-adenosylmethionin declines with age in humans. Biochem. Med. Metab. Biol. 44, 192-199 (1990).
56. Tint, G. S., Salen, G., Batta, A. K., Shefer, A., Irons, M., Elias, E. R., et al. Correlation of severity and outcome with plasma stenol levels in variants of the Smith-Lemli-Opitz syndrome. J. Pediatr 127, 82-87 (1995).
57. Wanders, R. A., Schutgens, R. B. H., Barth, P. G. Peroxisomal disorders: A review. J. Neuropathol. Exp. Neurol. 54, 726-739 (1995).
58. Wevers, R. A., Ingemann Hansen, S., van Hellenberg Hubar, J. L. M., Holm, J., Hoier-Madsen, M., Jongen, P. J. H. Folate deficiency in cerebrospinal fluid associated with a defect in folate binding protein in the central nervous system. J. Neurol. Neurosurg. Psychiatry 57, 223-226 (1994).
59. 1H-NMR spectroscopy in body fluids and leucocytes: a view on metabolism. Klin. Biochem. Metab. 4, 91-98 (1996).